Aerie Pharmaceuticals
Income Statement
Last updated:
Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. Aerie Pharmaceuticals's past years’ income statements indicate that its last revenue has increased compared to the previous period by 134% to $194,134,000. The net income raised on -$74,810,000 and profit margin reached -39%. Total operating expenses were $213,642,000.
Profit Margin
| 2012 | 0 | -14.97M | |
|---|---|---|---|
| 2013 | 0 | -31.14M | |
| 2014 | 0 | -48.13M | |
| 2015 | 0 | -74.36M | |
| 2016 | 0 | -99.05M | |
| 2017 | 0 | -145.10M | |
| 2018 | 24.18M | -232.56M | -961.78% |
| 2019 | 69.88M | -199.58M | -285.57% |
| 2020 | 83.13M | -183.10M | -220.24% |
| 2021 | 194.13M | -74.81M | -38.54% |
AERI Income Statement (2012 – 2021)
| 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | |
|---|---|---|---|---|---|---|---|---|---|---|
Revenue | ||||||||||
Revenue | 194.13M | 83.13M | 69.88M | 24.18M | 0 | 0 | 0 | 0 | 0 | 0 |
Cost of revenue | 26.84M | 25.33M | 4.83M | 641K | 0 | 0 | 0 | 0 | 0 | 0 |
Gross profit | 167.28M | 57.80M | 65.05M | 23.54M | 0 | 0 | 0 | 0 | 0 | 0 |
Operating exp. | ||||||||||
Research and development | 75.83M | 74.00M | 91.37M | 86.12M | 72.07M | 52.39M | 44.45M | 29.86M | 11.88M | 9.27M |
Selling and marketing | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Total operating expenses | 213.64M | 213.49M | 252.54M | 233.28M | 145.69M | 96.87M | 75.08M | 49.97M | 22.17M | 14.29M |
Operating income | -45.31M | -155.69M | -187.49M | -209.74M | -145.69M | -96.87M | -75.08M | -49.97M | -22.17M | -14.29M |
Other income (expenses), net | -28.90M | -22.16M | -12.17M | -22.82M | -1.17M | -1.99M | 862K | 1.83M | -8.97M | -685K |
Income before tax | -74.21M | -177.85M | -199.67M | -232.56M | -146.86M | -98.86M | -74.22M | -48.13M | -31.14M | -14.97M |
Income tax expense | 593K | 5.24M | -90K | 3K | -1.75M | 193K | 139K | 2.46M | -5.18M | 0 |
Net income | -74.81M | -183.10M | -199.58M | -232.56M | -145.10M | -99.05M | -74.36M | -48.13M | -31.14M | -14.97M |
Earnings per share | ||||||||||
Basic EPS | -1.61 | -3.99 | -4.39 | -5.58 | -4.11 | -3.4 | -2.88 | -2 | -6.29 | -0.91 |
Diluted EPS | -1.61 | -3.99 | -4.39 | -5.58 | -4.11 | -3.4 | -2.88 | -2 | -6.29 | -0.91 |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |